Rejection, Transplant Completed Phase 2 Trials for Human C1-esterase inhibitor (DB06404)

Also known as: Transplant Rejection / Transplant rejections / Graft Rejection

IndicationStatusPhase
DBCOND0030946 (Rejection, Transplant)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01147302A Pilot Study to Evaluate the Use of C1 Esterase Inhibitor (Human) in Patients With Acute Antibody-Mediated RejectionTreatment